Endocrine resistance and epigenetic reprogramming in estrogen receptor positive breast cancer. Dimitrakopoulos FI, Kottorou A, Tzezou A. Cancer Lett 2021 May 30. pii: S0304-3835(21)00254.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dimitrakopoulos FI, Kottorou A, Tzezou A. Endocrine resistance and epigenetic reprogramming in estrogen receptor positive breast cancer. Cancer Lett 2021 May 30. pii: S0304-3835(21)00254.
PMID: 34077785